Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Trading Update

1 Apr 2020 07:00

RNS Number : 3223I
Argentex Group PLC
01 April 2020
 

 

1 April 2020

Argentex Group PLC

Trading Update

Argentex Group PLC, ("Argentex" or "the Group"), the provider of foreign exchange services to institutions, corporates and high net worth private individuals, today issues a trading update for the 12 months to 31 March 2020.

 

Highlights for Argentex LLP (the Group's FCA regulated trading subsidiary), for the 12 months to 31 March 2020:

· Revenue increased by over 30% to c.£29m (2019: £21.9m)

· Strong client demand maintained during recent volatility

· Continuing rise in customer acquisition, adding 450 new corporate clients

· Robust business model and risk management systems supporting the Group's COVID-19 response

 

Revenue and trading

Argentex is expecting to report a c.30% increase in revenues to c.£29 million for the 12 months to 31 March 2020 (2019: £21.9 million), with Foreign Exchange ("FX") Turnover exceeding £12bn (2019: £10.8bn). The Group continues to experience very strong growth in customer numbers, adding 450 new corporate clients during the period, while corporate clients actively trading increased by 12%.  Following the Group's sustained excellent financial and operational progress, the Board is confident the Group will meet its full year profit expectations.

The Group's robust business model, balance sheet strength and approach to risk mitigation have ensured continuity of service for Argentex's diverse and sophisticated client base throughout the recent unprecedented market conditions resulting from the outbreak of COVID-19.

 

While client demand has grown throughout the period, the currencies traded has remained consistent with historic trends, and at the end of the period over 95% of the LLP's FX portfolio is comprised of Dollar, Sterling or Euro trades. Argentex's revenue composition has maintained historic stability between spot and forward, and furthermore there has been a positive uptake by the Group's professional clients for FX Options products in their commercial hedging. The options book continues to grow organically, and has reached the scale where it is now making a material revenue contribution.

 

COVID-19

Since the outbreak of COVID-19 and consequential government enforced actions, the priority has been to protect the health and safety of employees and their families. In line with government guidelines, Argentex has successfully implemented its Business Continuity Plan, requiring all staff to work remotely.

 

Operationally, Argentex's prudent and proactive approach to risk management and controls has resulted in no change to the trend of historically low levels of bad debt. Management continue to monitor client profiles, activity and macro-economic conditions as part of our rigorous processes, procedures and policies.

 

Harry Adams and Carl Jani, Co-CEOs commented:

 

"While it is too early to ascertain the full ramifications of COVID-19 on markets and corporates alike, the Group's high quality, credit worthy client base, risk framework and disciplined liquidity management positions the Group well in pursuit of its long-term growth objectives. Our continued strong performance underlines the commitment to our growth strategy and proven business model, and we are confident in our ability to deliver our leading FX services and advice to our clients, while generating returns to investors."

 

 

Timing of full year results

 

Following recent, market-wide regulatory communications from the FCA, PRA, FRC and London Stock Exchange regarding financial reporting, the announcement date of Argentex's full year results for the 12 months ending 31 March 2020 will be confirmed in due course.

 

-ENDS-

 

For further information please contact:

Argentex Group PLC

Carl Jani, Harry Adams - Co-CEOs

(Via FTI Consulting)

FTI Consulting (Financial PR)

Ed Berry, Antonia Powell

Telephone: 0203 727 1046

argentex@fticonsulting.com

 

Numis Securities Limited (Nominated Adviser and Broker)

Stephen Westgate, Charlie Farquhar, Laura White, Hugo RubinsteinTelephone: +44 (0) 20 7260 1000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKDBBDBKBFNN
Date   Source Headline
2nd Sep 20257:00 amRNSCancellation - Argentex Group PLC
7th Aug 20257:09 amRNSTermination of recommended cash acquisition by IFX
7th Aug 20257:00 amRNSLapsing of Acquisition
1st Aug 20259:37 amRNSResignation of Nominated Adviser and Broker
24th Jul 20253:29 pmRNSAppointment of Administrators
22nd Jul 20258:54 amRNSBoard change
21st Jul 20256:00 pmRNSAppointment of Special Administrators
21st Jul 20257:00 amRNSStatement re recommended acquisition of Argentex
18th Jul 20254:30 pmRNSIntention to Appoint Administrators
18th Jul 20257:00 amRNSAnnouncement of VREQ
17th Jul 20259:46 amRNSForm 8.5 (EPT/RI)
17th Jul 20257:30 amRNSSuspension - Argentex Group plc
17th Jul 20257:00 amRNSUpdate on Financial Position and Suspension
16th Jul 202510:41 amRNSForm 8.5 (EPT/RI)
15th Jul 202511:12 amRNSForm 8.5 (EPT/RI)
15th Jul 20258:57 amRNSForm 8 (DD) - IFX (UK) Ltd
14th Jul 202511:51 amRNSForm 8.5 (EPT/RI)
14th Jul 202510:24 amRNSForm 8 (DD) - IFX (UK) Ltd
11th Jul 202512:01 pmRNSForm 8.5 (EPT/RI)
10th Jul 202510:55 amRNSForm 8.5 (EPT/RI)
9th Jul 20259:48 amRNSForm 8.5 (EPT/RI)
9th Jul 20258:12 amRNSForm 8 (DD) - Argentex Group PLC
8th Jul 202510:47 amRNSForm 8.5 (EPT/RI)
8th Jul 20258:48 amRNSForm 8 (DD) - IFX (UK) Ltd
8th Jul 20257:00 amRNSAmendment to RCF & Announcement of VREQ
4th Jul 202510:04 amRNSForm 8.5 (EPT/RI)
3rd Jul 202512:11 pmRNSForm 8.5 (EPT/RI)
2nd Jul 202512:07 pmRNSForm 8.5 (EPT/RI)
1st Jul 202511:16 amRNSForm 8.5 (EPT/RI)
30th Jun 20254:43 pmRNSForm 8 (DD) - IFX (UK) Ltd - AMEND
30th Jun 202511:35 amRNSForm 8.5 (EPT/RI)
30th Jun 20259:48 amRNSForm 8 (DD) - IFX (UK) Ltd
27th Jun 202510:33 amRNSForm 8 (DD) - Argentex Group PLC
27th Jun 202510:03 amRNSForm 8.5 (EPT/RI)
26th Jun 202512:00 pmRNSAnnouncement of VREQ
26th Jun 202511:57 amRNSForm 8.5 (EPT/RI)
26th Jun 20259:13 amRNSForm 8 (DD) - Argentex Group PLC
25th Jun 202510:09 amRNSForm 8.5 (EPT/RI)
25th Jun 202510:08 amRNSForm 8 (DD) - Argentex Group PLC
24th Jun 202510:01 amRNSForm 8.5 (EPT/RI) Argentex Group PLC
23rd Jun 202510:33 amRNSForm 8 (DD) - Argentex Group PLC
23rd Jun 202510:12 amRNSForm 8.5 (EPT/RI)
20th Jun 202511:13 amRNSForm 8 (DD) - Argentex Group PLC
20th Jun 202510:09 amRNSForm 8.5 (EPT/RI)
19th Jun 202512:02 pmRNSForm 8.5 (EPT/RI)
18th Jun 202512:02 pmRNSForm 8.5 (EPT/RI)
17th Jun 20259:52 amRNSForm 8.5 (EPT/RI)
16th Jun 20259:19 amRNSForm 8.5 (EPT/RI)
13th Jun 202512:06 pmRNSForm 8.5 (EPT/RI)
12th Jun 202511:57 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.